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Trends
Distinct inﬂammasomes can be acti-
vated during sexually transmitted infec-
tions (STIs), often in discrete cell
compartments. The crosstalk between
multiple inﬂammasome sensors is cen-
tral to maintaining tissue homeostasis.
Contrary to popular belief, inﬂamma-
some activation can generate detri-
mental inﬂammatory responses
during STIs in vivo. The outcome of
inﬂammasome activity is governed by
the complex host–pathogen interaction
in the infected tissue.
Inﬂammasome effector molecules can
yield disparate functional conse-
quences in different tissues, suggest-
ing the need to employ appropriate
infection models.
Ligand internalization is not a neces-
sary prerequisite for cytosolic NLRP3
activation. Engagement of certain
plasma membrane-localized receptors
by sexually transmitted pathogens or
their ligands elicits both priming and
activation signals for the NLRP3
inﬂammasome.
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Inﬂammasomes are cytosolic multiprotein platforms with pivotal roles in infec-
tious diseases. Activation of inﬂammasomes results in proinﬂammatory cyto-
kine signaling and pyroptosis. Sexually transmitted infections (STIs) are a major
health problem worldwide, yet few studies have probed the impact of inﬂam-
masome signaling during these infections. Due to the dearth of appropriate
infection models, our current understanding of inﬂammasomes in STIs is mostly
drawn from results obtained in vitro, from distant infection sites, or from related
microbial strains that are not sexually transmitted. Understanding how inﬂam-
masomes inﬂuence the outcome of STIs may lead to the development of novel
and effective strategies to control disease and prevent transmission. Here we
discuss and highlight the recent progress in this ﬁeld.
Inﬂammasomes
Inﬂammasomes are multiprotein complexes activated in response to various pathogen-associ-
ated molecular patterns (PAMPs), such as bacterial lipopolysaccharide (LPS) and ﬂagellin, or in
response to cellular damage-associated molecular patterns (DAMPs), including extracellular
ATP and ﬂuctuations in cytoplasmic ion concentrations [1–3]. Detection of PAMPs or DAMPs
can occur via one of the cytoplasmic pattern recognition receptors of the NOD-like receptor
(NLR) or AIM2-like receptor (ALR) (also known as Pyhin proteins) family. These include, but may
not be limited to, NLRP1, NLRP3, NLRC4, AIM2, and IFI16 [4]. Following activation, the NLR or
ALR interacts with the adaptor protein apoptosis-associated speck-like protein containing a
CARD (ASC), which then recruits caspase-1 into the complex. Under certain conditions,
caspase-8 is also recruited into the inﬂammasome complex [5,6]. Activation of caspase-1 in
the inﬂammasome results in the proteolytic cleavage and activation of two important proin-
ﬂammatory cytokines, IL-1b and IL-18. Furthermore, inﬂammasome activation results in the
cleavage and activation of gasdermin D, which induces a proinﬂammatory form of cell death
known as pyroptosis [7,8]. Caspase-11 in mice (the ortholog of human caspase-4/5) is also
involved in NLRP3-mediated inﬂammasome activation in response to certain Gram-negative
bacterial infections [5,9–11]. NLRP3 inﬂammasome activation dependent on caspase-11 is
termed the noncanonical NLRP3 inﬂammasome and is initiated by cytoplasmic LPS that
activates caspase-11, which in turn activates gasdermin D and facilitates NLRP3-mediated
activation of caspase-1 [7–9]. Importantly, caspase-11 can induce pyroptosis, but not IL-1b
maturation, independently of caspase-1. [12]. Some inﬂammasomes, such as NLRP1b and
NAIP/NLRC4, are directly activated by bacterial PAMPs [13–15]. Other inﬂammasomes, like
NLRP3 and, under certain conditions, AIM2 require a priming step where their expression is
increased through activation of other signaling pathways such as Toll-like receptor (TLR) or type I
interferon (IFN-//b) signaling. This in turn activates the NF-kB, IRF-1, or STAT1/2 transcription
factors to increase the expression of NLRP3 and AIM2 as well as guanylate-binding proteins
(GBPs), caspase-11, pro-IL-1b, and pro-IL-18 [9,16–18].Trends in Immunology, October 2016, Vol. 37, No. 10 http://dx.doi.org/10.1016/j.it.2016.08.004 703
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Box 1. Innate Immunity in the Genital Tract
The reproductive system, of both males and females, is integral to the inner mucosal lining of the human body. Similar to
the mucosal tissues of the intestine and lungs, the reproductive tract is able to mount comprehensive immune responses
to pathogens. In addition to invading microbes, the female lower genital tract also contains a unique microﬂora. Thus, the
cervical and vaginal epithelial cells are in frequent contact with microorganisms while also occasionally facing antigenic
and inﬂammatory stimuli during intercourse [100]. Therefore, the genital tract is fortiﬁed by both innate and adaptive
immune responses. However, in keeping with its paramount role in reproduction, distinct adaptations have evolved.
The female genital mucosa comprises a single layer of tightly packed columnar epithelial cells in the upper reproductive
tract. By contrast, the lower reproductive tract is made of multiple layers of stratiﬁed squamous epithelium. The outer
epithelial layer is further coated on the luminal side by a thick mucus layer comprising glycosylated proteins known as
mucins. Together, epithelial cells and the mucus layer form both physical and immunological barriers to prevent infection
and transmission of STIs; nonetheless, invasion does occur. Once these barriers are breached by pathogens, epithelial
cells are infected followed by the activation of macrophages and DCs. These tissue-resident macrophages and DCs
endeavor to eliminate the infectious agent by phagocytosis while augmenting cytokine and chemokine production to
expand cellular recruitment. Moreover, activated DCs serve to bridge innate and adaptive immunity by migrating into
draining lymph nodes where they prime antigen-speciﬁc T cells and initiate B cell responses [100–103].
In addition to the expression of inﬂammasome sensors (which are discussed in detail below), several PRRs are expressed
in the epithelial cells of the reproductive tract. The NLRs NOD1 and NOD2 and their adaptor protein RIP2 are expressed in
the human endometrium [104,105]. In addition, TLRs including TLR1, 2, 3, and 6 are found in the genital mucosal
epithelium [101]. Some of the TLRs have a unique site-speciﬁc expression pattern in the reproductive tract tissue [105–
110]. For example, TLR4 is mainly expressed in the upper genital tract and the expression gradually decreases in the
lower genital tract [105,108,110]. It has been suggested that this gradient of TLR distribution is likely to reﬂect the
immunologic tolerance of the lower genital tract to commensal organisms while maintaining a ﬁrm intolerance to
commensals and pathogens in the upper genital tract, which is important for reproduction. Thus, commensal ﬂora,
but also reproductive hormones and locally available cues, shape the immune responses and differentiation of cells in the
upper and lower genital tract. The role of these factors as well as non-inﬂammasome PRRs in the reproductive system are
discussed in depth elsewhere [101,103,111,112]. However, many non-inﬂammasome PRRs have essential roles in
priming inﬂammasomes, as discussed above and thus a discussion of their importance relative to inﬂammasome
activation during STIs is included.STIs are a major health problem worldwide. Despite extensive efforts and recent awareness, only
limited success has been achieved in defying STIs. The World Health Organization (WHO)
estimates that more than 1 million new STIs occur every day globally. In the USA alone, there are
110 million total STIs and 20 million new infections are acquired each year, with young people
being particularly at risk and costing tens of billions of dollars in treatment [19,20]. Although exact
statistics are unavailable, it is believed that there is a signiﬁcantly higher burden in less-developed
countries where the social stigma associated with STIs results in underreporting. Inﬂamma-
somes have emerged as critical hubs of innate immunity in infectious diseases, yet only a limited
number of studies have investigated the impact of inﬂammasome signaling in STIs. It is
becoming increasingly clear that innate immunity and inﬂammasomes mediate important
functions in the genital tract (Box 1). Table 1 lists the inﬂammasome receptors and their known
activation signals during STIs. However, lack of appropriate models that employ vaginal or other
relevant in vivo infection routes limits our understanding of the importance of inﬂammasomes
during STIs. Furthermore, several pathogens that cause STIs are restricted to humans and
the development of validated surrogates or new infection models is needed. Below we review
the current state of understanding of inﬂammasome signaling during STIs with emphasis on the
involvement of the inﬂammasome in animal models or clinical samples.
Mechanisms of Inﬂammasome Activation in STIs
Understanding the mechanism by which pathogens activate the inﬂammasome not only
enhances our basic understanding of the mechanisms of disease but also provides useful
insight into potential therapeutic strategies. Candida albicans is the major fungal species known
to cause STI. C. albicans is generally a commensal organism but may cause superﬁcial mucosal
diseases, oropharyngeal candidiasis (thrush), or vulvovaginal candidiasis (VVC) in immunocom-
promised individuals. Studies estimate that 75% of healthy women are also at risk of VVC.704 Trends in Immunology, October 2016, Vol. 37, No. 10
Table 1. Ligands of Inﬂammasome Sensors in STIs.
PRR STI PAMP/DAMP Pathogen Refs
NLRP3 Secreted aspartyl proteinases,
ROS, K+ efﬂux, and other cellular
damage signals
HPV [87]
HSV [58,64]
HIV [73,80,93–96]
Chlamydia trachomatis,
Chlamydia muridarum
[46,47,81]
Neisseria gonorrhoeae [37]
Treponema pallidum [39,41]
Candida albicans [6,24,27,28,31,32,36,68]
NLRC4 Flagellin, T3SS components,
or unknown fungal ligands
C. albicans [36,68]
AIM2 Cytoplasmic dsDNA HPV [92]
HSV [65]
Chlamydia [97]
IFI16 Nuclear dsDNA HSV [64,98,99]
HIV [75–77,79]Candida sp. are recognized by multiple pattern recognition receptors (PRRs), but the Dectin-1/
Syk pathway in particular has emerged as an important component of the host arsenal for
Candida recognition and modulates various immune functions [6,21–25]. Deﬁciency in Dectin-1
is linked to the development of mucocutaneous infections in humans and highlights the essential
nature of this pathway [26]. NLRP3 is the primary inﬂammasome activated by C. albicans in vitro
and in vivo. Engagement of Dectin-1 and the downstream adaptor Syk provides the necessary
priming and activation signals for the canonical NLRP3 inﬂammasome [24]. By contrast, certain
C. albicans strains trigger the noncanonical caspase-8 inﬂammasome in dendritic cells (DCs)
through the assembly of a CARD9–Bcl-10–MALT1 complex [6]. Intriguingly, this noncanonical
pathway of inﬂammasome activation is triggered extracellularly by Dectin-1 ligation and Candida
internalization is not necessary [6]. Overall, these studies suggest redundancy in pathways for
inﬂammasome assembly through the same upstream sensor. In addition, Candida displays
remarkable morphological plasticity by switching from the yeast to a ﬁlamentous hyphal form, a
key feature enabling adherence and tissue invasion at mucosal surfaces. This alteration results in
NLRP3 activation by exposing the Dectin-1 ligand, b-glucan, which is normally shielded from
recognition by mannoproteins. Accordingly, both the yeast form and mutant strains lacking Egf1,
a principal regulator of ﬁlamentation, are incompetent in NLRP3 activation [24,27,28]. Highly
polarized hyphae may also inﬂict physical damage on the host cell via rupture of phagosomal and
cell membranes, thereby generating DAMPs for NLRP3 activation. However, these ﬁndings have
been challenged by the discovery of mutant strains that fail to activate NLRP3 yet assemble
normal hyphal ﬁlaments [29,30], thereby signifying the involvement of additional, unrecognized
microbial factors in NLRP3 activation.
Another important determinant of Candida pathogenesis, and inﬂammasome activation, is the
extracellular proteolytic activity produced by a family of ten secreted aspartyl proteinases (Saps).
Besides their plausible role in the evasion of host immunity, Saps also enable the fungus to
adhere and invade host tissues. Family member Sap2 activates the NLRP3 inﬂammasome in
vitro and in vivo, where vaginal inoculation of the puriﬁed full-length Sap2 resulted in local
neutrophil inﬂux and IL-1b accumulation in the vaginal ﬂuid [31,32]. These measurements
decreased on treatment with anti-Sap2 antibody or infection with mutant Candida DSap1–3Trends in Immunology, October 2016, Vol. 37, No. 10 705
[32]. Whether Sap2's enzymatic activity is also required to trigger the inﬂammasome is unclear,
as contradictory results exist in vitro and in vivo. It has been suggested that Sap2 activity serves
only to hydrolyze the mucosal layer for efﬁcient Candida invasion in vivo [31]. Any direct role for
Sap2 enzymatic activity in inﬂammasome activation remains to be determined. In addition, these
studies need further validation, as the yeast form of Candida produces Sap2 but is not an
effective inﬂammasome activator [33–36]. Hypha-associated members Sap4, 5, and 6 are also
expressed robustly during VVC [33–36]. In contrast to the previous study, intravaginal challenge
with DSap5 mutant but not the triple knockout DSap1–3 resulted in reduced IL-1b secretion and
polymorphonuclear leukocyte (PMN) ﬂux [36]. These differences in results could be due to the
different genetic background of animals used and/or differences in the preparation and dose of
Candida infection. Although conﬂicting, these studies propose essential functions for Saps in
inﬂammasome-mediated immunopathogenesis of VVC. However, more evidence is needed to
identify the important Saps, which should enable improved understanding of the complex
interplay between host and pathogen at the vaginal interface.
Neisseria gonorrhoeae, the causative agent of gonorrhea, results in acute urethritis and cervicitis
in males and females, respectively. Neisseria lipooligosaccharide (LOS), a modiﬁed form of LPS,
has been suggested to activate the NLRP3 inﬂammasome and IL-1b secretion in a cathepsin-B-
dependent manner [37] (Figure 1). However, invasion of the host cytosol by N. gonorrhoeae, or a
role for additional gonococcal antigens as possible NLRP3 activators, cannot be completely
excluded. Similar to gonorrhea LOS, Treponema pallidum TpF1, a bacterioferritin and a major
virulence factor of this spirochete, also activates the NLRP3 inﬂammasome. T. pallidum causes
syphilis, a sexually transmitted chronic inﬂammatory disorder that is characterized by mucocu-
taneous rash with enhanced vascular inﬂammation and angiogenesis [38]. TpF1 elicits pro-IL-1b
production by monocytes, thus priming the inﬂammasome, and triggers the secretion of ATP, a
known activator of NLRP3 [39]. Thus, TpF1 delivers both of the signals required for inﬂamma-
some activation (Figure 1). A related treponeme, Treponema denticola, implicated in human
periodontal disease, also activates the NLRP3 inﬂammasome. Although rare, T. denticola may
cause vaginitis and affect preterm delivery [40]. Interaction of Td92, a T. denticola surface
protein, with monocyte membrane integrin /5b1 prompted ATP release and K+ efﬂux preceding
NLRP3 activation [41]. Contrary to the requisite cytosolic presence of microbial ligands for
NLRP3 trigger, activation by Td92 is independent of its internalization, and direct binding of
recombinant Td92 to the glycosylated b1 subunit of integrin is mandatory for inﬂammasome
activation (Figure 1).
Positive and Negative Consequences of NLRP3 Inﬂammasome Activation
During infection, mice lacking Nlrp3 display enhanced susceptibility to various infectious agents.
By contrast, gain-of-function mutations in the Nlrp3 gene lead to inﬂammatory diseases together
known as cryopyrin-associated periodic syndromes (CAPSs). Thus, the role of the NLRP3
inﬂammasome is highly context dependent. In the case of sexually transmitted diseases, the
importance of inﬂammasome activation in vivo is similarly context dependent and the use of
appropriate models for the study of STIs is needed. Chlamydia trachomatis infection results in
scarring of the ovaries and Fallopian tubes and is considered the leading cause of tubal infertility.
Even when procreation is achieved, infection may result in ectopic pregnancy, preterm birth, and
vertical transmission to the developing fetus [42,43]. Much of our understanding of the patho-
genesis of and immune responses to C. trachomatis has developed through equivalent mouse
models of Chlamydia muridarum, where the genital tract pathology is comparable to that in
humans [44,45]. Chlamydia infection activates the NLRP3 inﬂammasome (Figure 1). Surpris-
ingly, caspase-1 deﬁciency resulted in similar C. muridarum growth in the intravaginally infected
mouse model, and the levels of shed live organisms were comparable at days 17 and 21 post-
infection [46]. In terms of genital tract pathology, abolition of caspase-1 or IL-1 receptor (IL-1R)
signaling reduced inﬂammatory damage in the oviducts [46,47]. Of note, the pathology does not706 Trends in Immunology, October 2016, Vol. 37, No. 10
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Figure 1. Inﬂammasome Activation Mechanisms during Bacterial Sexually Transmitted Infections (STIs). Activation of the NLRP3 inﬂammasome occurs
through the ligation of various pattern recognition receptors (PRRs). Chlamydia is taken up in a vacuole known as an inclusion, where activity of the Chlamydia type III
secretion system triggers the NLRP3 inﬂammasome. Neisseria releases membrane lipooligosaccharide, which has been suggested to activate the NLRP3 inﬂammasome
through a cathepsin-B-dependent pathway. Treponema surface proteins TpF1 and Td92 activate the NLRP3 inﬂammasome dependent on K+ efﬂux. Since our
understanding of inﬂammasomes and their activation mechanisms is incomplete in bacterial STIs, other mechanisms may also be involved. It is also unclear whether the
same mechanisms are important in vivo.appear to be affected in Nlrp3-deﬁcient mice [47], suggesting that other inﬂammasomes may be
involved. One hypothesis postulates that inﬂammasome-mediated pathology is due to rapid IL-
1b-mediated PMN inﬂux. Accordingly, abrogation of IL-1R signaling diminished pathology in the
genital tissue and correlated with reduced PMN recruitment [47]. It is intriguing to consider that
the inﬁltrated neutrophils can also supplement active IL-1b through cleavage of the precursor
form by neutrophil proteases and thus exacerbate oviduct pathology during intravaginal chal-
lenge. Overall, these studies suggest that the inﬂammasome per se does not affect intravaginal
Chlamydia colonization but augments detrimental pathology in the upper genital tract during the
innate phase of infection.
Inﬂammasome activation also appears detrimental during VVC. Experiments in wild-type (WT)
mice implicated NLRP3 activity as the source of increased PMN recruitment, increased pro-
duction of alarmins, and elevated levels of IL-1b in vaginal lavage ﬂuid during VVC. Consequently,
infection in Nlrp3-deﬁcient mice or treatment of WT mice with the NLRP3 inhibitor glyburide
reduced C. albicans vaginitis without affecting microbial colonization [36].Trends in Immunology, October 2016, Vol. 37, No. 10 707
Contrary to results described during genital infection, inﬂammasome activation during C.
pneumoniae lung infection is critical for both elimination of the pathogen and protection from
lung ﬁbrosis [48,49]. Independent reports suggest that C. pneumoniae may also activate
cytosolic sensors distinct from those activated by C. muridarum or C. trachomatis [50,51].
Similarly, mice lacking components of the NLRP3 inﬂammasome and upstream fungal recogni-
tion receptors are susceptible to disseminated candidiasis [24,28,52]. In addition, deﬁciency in
IL-1b, or loss of IL-1R signaling, promotes susceptibility due to the impact of this pathway on
granulocyte inﬂux and superoxide production [53]. Finally, administration of recombinant IL-18
protects against infection, and this occurs through the restoration of type 1 immunity [54–56].
Overall, the results obtained from vaginal infection with either Chlamydia or Candida suggest that
systemic infection or infection at distal sites with similar pathogens cannot be used to infer the
roles of the inﬂammasome in the genital tract. Instead, appropriate pathogen strains and
infection routes are essential to elucidate a clear picture of the function of inﬂammasomes in
STIs.
Vaginal infection in a mouse model of HSV-2 demonstrated that Il18/ mice died sooner than
WT mice and viral titers were higher in Il18/ mice on day 3 after infection [57]. However,
following secondary challenge with HSV-2 in a memory recall experiment, Il18/mice were fully
protected, suggesting that IL-18 is not required for the development of appropriate immune
memory [57]. Unfortunately, little else has been reported regarding the importance of the
inﬂammasome for HSV-2. Increased inﬂammasome activation was also associated with
increased protection from HSV-1 infection but in an ocular infection model [58]. A second
report showed that Nlrp3/mice are more susceptible to HSV-1 infection in an ocular infection
model, but this was independent of inﬂammasome activation [59]. Indeed, the latter study
reported that IL-1b levels were higher in Nlrp3/mice following HSV-1 infection and noted that
NLRP3 was localized to the nucleus. The authors hypothesized that NLRP3 has an inﬂamma-
some-independent function in immune regulation that helps to suppress deleterious inﬂamma-
tion in the ocular model of HSV-1 infection [59]. NLRP3 reportedly has inﬂammasome-
independent roles [60–63] but more research is needed to fully understand these potential
functions. Furthermore, inﬂammasome activation may be important in ocular models, but
whether this activity will be recapitulated during sexual transmission is unclear as activation
of the inﬂammasome in human keratinocytes did not affect HSV-1 replication [64,65] and
inﬂammasome activation in vaginal models of HSV-1 have not been reported.
Interplay between Distinct Inﬂammasomes
Infection with a pathogen can concurrently engage multiple inﬂammasome sensors [66,67]. A
recent ﬁnding demonstrated the complex interplay of NLRP3 and NLRC4 during C. albicans
infection in the vaginal tissue [68]. The expression of both of the inﬂammasome-activating
sensors was augmented during VVC; however, NLRP3 expression peaked earlier in the vaginal
tissue than the active phosphorylated form of NLRC4 (pNLRC4), which increased even further
under Nlrp3-deﬁcient conditions [68]. Further mechanistic studies associated NLRC4 activation,
through an IL-22- and PKCd-mediated pathway, with dampening exaggerated inﬂammation
through the production of IL-1 receptor antagonist (IL-Ra) (Figure 2, Key Figure). Intriguingly,
PKCd is critical downstream of several Syk-coupled CLRs with roles in antifungal immunity,
including Dectin-1, Dectin-2, and Mincle [69]. Accordingly, IL-22 administration in vivo damp-
ened cytotoxic damage in the vaginas of infected mice. Conversely, treatment with an inhibitor of
PKCd decreased pNLRC4 expression and enhanced NLRP3-associated vaginitis [68]. These
studies suggest that NLRC4 negatively regulates NLRP3 activity (Figure 2). Additionally, they
suggest that sustained production of IL-1Ra by NLRC4 dampens NLRP3-mediated inﬂamma-
tion during VVC. Although VVC and oropharyngeal candidiasis involve similar inﬂammasomes,
their activation seems to produce opposite results. During oropharyngeal candidiasis, akin to
VVC, both NLRP3 and NLRC4 inﬂammasomes regulate IL-1b production. However, epithelial708 Trends in Immunology, October 2016, Vol. 37, No. 10
Key Figure
NLRP3 and NLRC4 Inflammasomes Mediate Distinct Host Immune Responses during Candida
albicans Vaginal and Oral Infection
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Figure 2. (A) During vulvovaginal candidiasis, NLRP3 activation leads to IL-1b and IL-18 production. NLRP3 activity restrains fungal colonization while increasing
polymorphonuclear leukocyte (PMN) ﬂux to the vaginal tissue, through IL-1b production, leading to vaginitis. IL-18, by contrast, increases the amount of available IL-22 by
decreasing the levels of IL-22-binding protein (IL-22 bp). Furthermore, IL-22 leads to phosphorylation, and thus activation, of epithelial NLRC4 and results in increased
production of IL-1 receptor antagonist (IL-1Ra) thereby limiting NLRP3 activity. (B) During oropharyngeal candidiasis (thrush), epithelial NLRC4, more than NLRP3,
regulates fungal colonization and PMN ﬂux in the buccal cavity. NLRP3 activity, in both epithelial and myeloid cells, serves critical roles in protection against disseminated
candidiasis.Nlrc4 deﬁciency, more than Nlrp3, resulted in signiﬁcantly enhanced Candida buccal load
throughout the 21-day infection period and increased inﬂammatory cell recruitment in the
tongue epithelium despite the presence of erosive lesions and hyphae [70] (Figure 2). Notably,
Nlrp3 deﬁciency resulted in only slightly elevated oral colonization and gross clinical score [70].
Thus, although both oral and vaginal infections are clinical manifestations of mucosal infection,
inﬂammasome activation and enhanced PMN inﬁltration leads to contrasting results at the two
sites.
Inﬂammasome-Induced Pyroptosis in STIs
HIV is one of the most concerning worldwide pandemics, with approximately 37 million people
infected with a virus that causes lifelong morbidity and eventual mortality [71]. HIV infection
results in the activation of both the NLRP3 and IFI16 inﬂammasomes (Figure 3). In monocytes,
the NLRP3 inﬂammasome is activated in response to HIV infection as a result of TLR8-mediatedTrends in Immunology, October 2016, Vol. 37, No. 10 709
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Figure 3. Pyroptosis during HIV Infection Contributes to Disease. During HIV infection, different inﬂammasomes are
activated in different cell types and in response to different stimuli. However, in all cell types inﬂammasome activation causes
maturation of IL-1b and the inﬂammatory form of cell death, pyroptosis. Pyroptosis in CD4+ T cells contributes to
immunodeﬁciency by further depleting CD4+ T cell numbers, whereas pyroptosis of podocytes in the kidney results in
HIV-associated nephropathy.priming and reactive oxygen species (ROS) production [72–74]. However, IFI16 appears to be
the predominant inﬂammasome activated in CD4+ T cells and may lead to AIDS progression [75].
Activation of inﬂammasomes results in a programmed cell death termed pyroptosis. Pyroptosis
of the infected cells results in destruction of the pathogen replicative niche. However, because of
the inherently inﬂammatory nature of this form of cell death, it may promote tissue damage. IFI16
activation and pyroptosis in response to HIV infection results in the depletion of resting CD4+ T
cells, which further exacerbates immunodeﬁciency [75–78]. Direct infection of CD4+ T cells does
not appear to result in pyroptosis. Instead, cell-to-cell transmission though the virus synapse
results in abortive infection of resting CD4+ T cells and the accumulation of reverse-transcribed
HIV genomes in the cell (Figure 3). These DNA molecules are then sensed by the IFI16
inﬂammasome resulting in pyroptosis [79]. Interestingly, cell-to-cell spread occurs most efﬁ-
ciently in the lymph node environment and not in blood-circulating CD4+ T cells [76]. In the
kidneys, HIV-associated nephropathy results from the loss of podocytes. Recent research
suggests that NLRP3 inﬂammasome activation in the kidneys during HIV infection causes
pyroptotic cell death of podocytes and contributes to kidney damage (Figure 3) [80]. Further-
more, inhibition of ROS or the NLRP3 inﬂammasome resulted in improved podocyte survival in
the Tg26 transgenic mouse model of HIV infection [80]. Overall, inﬂammasome activation by HIV
appears to do more harm than good, and it will be of interest to determine the therapeutic
potential of inﬂammasome inhibition.
Induction of pyroptosis during Chlamydia infection causes injury to the upper genital tract
resulting in degeneration of oviduct epithelia, swollen oviducts, and widespread necrosis of the
endometrium [81]. Inﬂammasome assembly was demonstrated to induce pyroptosis in anti-
gen-presenting DCs in an IL-10-dependent manner [81]. Consequently, IL-10 abolition
reduced inﬂammasome activation and limited necrosis in the endometrium. Additionally,
Chlamydia-infected Il10-deﬁcient mice had 100% fertility but Chlamydia-infected WT mice
suffered signiﬁcant fertility impairment. However, mechanistic pathways coupling IL-10 to
NLRP3 in DCs remain unclear. Furthermore, these results appear contradictory to the emerg-
ing role of IL-10 as a negative regulator of inﬂammasome signaling [82,83]. Nonetheless, the
inﬂammasome-dependent pathology encountered by the host seems to be restricted to710 Trends in Immunology, October 2016, Vol. 37, No. 10
Outstanding Questions
Which inﬂammasome types are critical
in the genital tract? What are the molec-
ular pathways that activate inﬂamma-
somes in the genital mucosa? We
have increased understanding of
inﬂammasome signaling in hematopoi-
etic cells but our knowledge of immune
receptors and inﬂammasome activation
mechanisms in the mucosal epithelium
is rather limited.
What are the roles of the noncanonical
NLRP3-dependent and NLRP3-inde-
pendent inﬂammasomes? Recent
reports have suggested key roles for
inﬂammasomes other than NLRP3 dur-
ing a wide variety of infections. How-
ever, their roles in STIs remain
ambiguous. For example, activation of
the AIM2 inﬂammasome by Candida
sp. was recently described in macro-
phages. Does AIM2 also inﬂuence pro-
gression of vulvovaginal candidiasis?
What is the role of autophagy during
STIs? Both autophagy of pathogens
(xenophagy) and autophagic degrada-
tion of inﬂammasomes and precursor
IL-1b by macroautophagy are now
considered important mechanisms
contributing to infection outcome.
However, these mechanisms have
not been characterized in STIs.
Which host pathways function as rheo-
stats between pathogen elimination and
exaggerated inﬂammatory responses?
Since inﬂammasomes have both bene-
ﬁcial and detrimental roles, there is a
need to identify targets that can speciﬁ-
cally activate or dampen inﬂammasome
activity. Knowledge in this area can help
us develop appropriate therapeutic
interventions.
What are the functional consequences
of inﬂammasome gene polymorphisms
in the human population? Numerous
studies report that speciﬁc alleles of
genes encoding inﬂammasome com-
ponents are associated with increased
propensity to infection or severe dis-
ease, but the functional consequences
of these alleles and how they predis-
pose patients to disease are unknown.primary infection, as pathology encountered during recurrent infections is propagated by
adaptive immunity [46].
Polymorphism or Expression Changes in Inﬂammasome-Coding Genes
The role of inﬂammasomes during VVC is also corroborated by studies in humans where
polymorphism in the gene encoding Nlrp3 is associated with increased incidence of recurrent
VVC (RVVC), which is characterized by at least three episodes of infection per year [84,85]. One
study measured inﬂammasome-dependent cytokine production at the mucosal surface and
observed enhanced IL-1b levels in the vaginal ﬂuid of RVVC patients compared with healthy
controls. Intriguingly, RVVC patients bearing the risk allele demonstrated even higher levels of IL-
1b production [84]. In agreement, IL-1Ra levels were lower in recurrent VVC patients. Addition-
ally, IL-18 levels were unaltered in the vaginal ﬂuid of patients bearing the risk allele [84]. These
studies thus argue that genetic variations in the Nlrp3 gene may inﬂuence the progression of VVC
and identify IL-1b as a therapeutic target in the management of RVVC.
Several targeted genetic association studies have found that certain alleles of IL-1b, IL-18,
NLRP3, and NLRP1 are associated with resistance or susceptibility to more severe human
papillomavirus (HPV) outcomes such as cervical cancer [86,87]. Two other studies reported
downregulation of the expression of IL-1b and other inﬂammasome-related genes in patients
who are HPV infected or have developed cervical cancer [88,89]. Furthermore, elevated IFI16
and AIM2 expression is associated with HPV infection and HPV-associated cancer development
[88,90,91]. AIM2 may respond to HPV infection of human keratinocytes by detecting viral DNA in
the cytoplasm. However, this ﬁnding was not based on a natural infection. Instead, viral genomic
DNA was transfected into keratinocytes; thus, the role of AIM2 during natural HPV infection is
unknown [92]. Finally, inﬂammasome activation during HIV infection results in negative immu-
nopathologic effects as described above. It is thus interesting to note that polymorphisms in
NLRP3 and IL-1b are found more commonly in HIV-positive individuals than in uninfected
individuals [93,94]. Although the functional consequences of these polymorphisms are
unknown, it will be of interest to determine whether they enhance or inhibit inﬂammasome
activation, potentially facilitating pyroptotic cell death and leading to disease progression or
resulting in impaired immunity with increased disease susceptibility.
Concluding Remarks
The contributions of inﬂammasomes during STIs are only beginning to be understood. Recent
studies have depicted the signiﬁcance of inﬂammasomes in vitro in response to sexually
transmitted pathogens. However, few in vivo studies have been conducted and this remains
challenging because of the topology of infection site and lack of appropriate animal models that
faithfully recapitulate the infection. Nevertheless, a few well-controlled studies employing intra-
vaginal challenge models of Candida and Chlamydia have depicted detrimental roles of inﬂam-
masomes in the genital tract, in contrast to results observed in vitro and in systemic models of
infection. These signiﬁcant differences highlight the importance of performing discovery-based
experiments using speciﬁc models instead of drawing conclusions solely from related studies.
These studies also illustrated activation of distinct inﬂammasomes in hematopoietic and stromal
compartments, thereby highlighting the need to develop tissue-speciﬁc models and conditional
knockouts that accurately measure the contribution of each inﬂammasome type. Nevertheless,
whether the detrimental role of inﬂammasomes in the genital tract extends to other STIs remains
to be examined. Regardless of the infection, improved models of STIs are needed to better
understand the role of inﬂammasomes in STIs. Especially, there is a need for the development of
models that recapitulate the initial sexual transmission of the infection and allow examination of
the initial immune responses that are involved in facilitating or preventing disease transmission.
There is little doubt that inﬂammasomes are activated during STIs. The major question is which
inﬂammasome types are important in the skin and mucosal tissues? Also, what are the preciseTrends in Immunology, October 2016, Vol. 37, No. 10 711
pathways that pair each STI to a speciﬁc inﬂammasome? These and other questions remain
enigmatic (see Outstanding Questions), but by understanding the nature of protection and
damage mediated by inﬂammasomes these studies will further advance our knowledge and are
essential for reproductive health. Finally, an improved grasp of the role of inﬂammasomes in the
genital tract may translate into new therapeutic opportunities to reduce morbidity and mortality
due to STIs.
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